| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |